{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:32:00Z","timestamp":1761129120585},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00198-013-2545-9","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T10:46:03Z","timestamp":1382006763000},"page":"1181-1185","source":"Crossref","is-referenced-by-count":6,"title":["Diffuse osteosclerosis in a patient with prostate cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"N.","family":"\u00dcst\u00fcn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Atci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. T.","family":"S\u00fcmb\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Turhano\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"2545_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.eururo.2005.12.045","volume":"49","author":"F Saad","year":"2006","unstructured":"Saad F, Clarke N, Colombel M (2006) Natural history and treatment of bone complications in prostate cancer. Eur Urol 49:429\u2013440","journal-title":"Eur Urol"},{"key":"2545_CR2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2011-3058","volume":"97","author":"MT Drake","year":"2012","unstructured":"Drake MT, Murad MH, Mauck KF, Lane MA, Undavalli C, Elraiyah T et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861\u20131870","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","volume":"23","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA et al (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23:2735\u20132748","journal-title":"Osteoporos Int"},{"key":"2545_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:8:1:001","volume":"8","author":"MP Whyte","year":"2005","unstructured":"Whyte MP (2005) Misinterpretation of osteodensitometry with high bone density: BMD Z\u2009>\u2009or\u2009=\u2009+ 2.5 is not \u201cnormal\u201d. J Clin Densitom 8:1\u20136","journal-title":"J Clin Densitom"},{"key":"2545_CR5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/ket007","volume":"52","author":"CL Gregson","year":"2013","unstructured":"Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology 52:968\u2013985","journal-title":"Rheumatology"},{"key":"2545_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","volume":"26","author":"OD Benichou","year":"2000","unstructured":"Benichou OD, Laredo JD, de Vernejoul MC (2000) Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients. Bone 26:87\u201393","journal-title":"Bone"},{"key":"2545_CR7","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1148\/rg.317115093","volume":"31","author":"LL Ihde","year":"2011","unstructured":"Ihde LL, Forrester DM, Gottsegen CJ, Masih S, Patel DB, Vachon LA et al (2011) Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics 31:1865\u20131882","journal-title":"Radiographics"},{"key":"2545_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","volume":"28","author":"AH Lierop van","year":"2013","unstructured":"van Lierop AH, Hamdy NA, van Egmond ME, Bakker E, Dikkers FG, Papapoulos SE (2013) Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers. J Bone Miner Res 28:848\u2013854","journal-title":"J Bone Miner Res"},{"key":"2545_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.2531080011","volume":"253","author":"M Wengenroth","year":"2009","unstructured":"Wengenroth M, Vasvari G, Federspil PA, Mair J, Schneider P, Stippich C (2009) Case 150: Van Buchem disease (hyperostosis corticalis generalisata). Radiology 253:272\u2013276","journal-title":"Radiology"},{"key":"2545_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M et al (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537\u2013543","journal-title":"Hum Mol Genet"},{"key":"2545_CR11","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","volume":"281","author":"MV Semenov","year":"2006","unstructured":"Semenov MV, He X (2006) LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem 281:38276\u201338284","journal-title":"J Biol Chem"},{"key":"2545_CR12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"2545_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2005.033522","volume":"43","author":"K Janssens","year":"2006","unstructured":"Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S et al (2006) Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet 43:1\u201311","journal-title":"J Med Genet"},{"key":"2545_CR14","unstructured":"Wallace SE, Wilcox WR. Camurati-Engelmann Disease. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews. Seattle WA: University of Washington, Seattle; 1993."},{"key":"2545_CR15","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2001-011428","volume":"88","author":"C Hernandez-Cassis","year":"2003","unstructured":"Hernandez-Cassis C, Vogel CK, Hernandez TP, Econs MJ, Iglesias M, Iglesias A et al (2003) Autosomal dominant hyperostosis\/osteosclerosis with high serum alkaline phosphatase activity. J Clin Endocrinol Metab 88:2650\u20132655","journal-title":"J Clin Endocrinol Metab"},{"key":"2545_CR16","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","volume":"10","author":"E Cleiren","year":"2001","unstructured":"Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR et al (2001) Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10:2861\u20132867","journal-title":"Hum Mol Genet"},{"key":"2545_CR17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.urolonc.2007.05.027","volume":"26","author":"H Perk","year":"2008","unstructured":"Perk H, Yildiz M, Kosar A, Cerci S, Soyupek F, Ozorak A et al (2008) Correlation between BMD and bone scintigraphy in patients with prostate cancer. Urol Oncol 26:250\u2013253","journal-title":"Urol Oncol"},{"key":"2545_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1081\/ERC-120022298","volume":"29","author":"CH Chang","year":"2003","unstructured":"Chang CH, Tsai CS, Jim YF, Wu HC, Lin CC, Kao A (2003) Lumbar bone mineral density in prostate cancer patients with bone metastases. Endocr Res 29:177\u2013182","journal-title":"Endocr Res"},{"key":"2545_CR19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10555-006-9034-y","volume":"25","author":"MB Choueiri","year":"2006","unstructured":"Choueiri MB, Tu SM, Yu-Lee LY, Lin SH (2006) The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev 25:601\u2013609","journal-title":"Cancer Metastasis Rev"},{"key":"2545_CR20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/cncr.24896","volume":"116","author":"T Ibrahim","year":"2010","unstructured":"Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D (2010) Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer 116:1406\u20131418","journal-title":"Cancer"},{"key":"2545_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003072-199403000-00005","volume":"19","author":"B Brown","year":"1994","unstructured":"Brown B, Laorr A, Greenspan A, Stadalnik R (1994) Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases. Clin Nucl Med 19:194\u2013196","journal-title":"Clin Nucl Med"},{"key":"2545_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00345-010-0630-7","volume":"29","author":"J Morote","year":"2011","unstructured":"Morote J, Planas J, Mir MC, Raventos CX, Encabo G, Doll A (2011) 33% radius evaluation to assess bone mineral density in prostate cancer patients. World J Urol 29:815\u2013819","journal-title":"World J Urol"},{"key":"2545_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/PPO.0b013e318281197e","volume":"19","author":"A Alva","year":"2013","unstructured":"Alva A, Hussain M (2013) The changing natural history of metastatic prostate cancer. Cancer J 19:19\u201324","journal-title":"Cancer J"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2545-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2545-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:57Z","timestamp":1558624137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2545-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2545-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}